Figure 1
Figure 1. Proliferation and cytokine secretion of T-cell clones isolated from subject 17A 19 weeks and 21 months after inhibitor development and from subject 32A at one time point. Resting T-cell clones were stimulated with FVIII2194-2213 (0.1, 1.0, and 10 μM) presented on irradiated PBMCs from an unrelated DRB1*0101 donor. Proliferation (n = 3) was measured by addition of [3H]thymidine at 48 hours, and cells were harvested 18 hours later (A). Cell supernatants were collected after 48 hours to measure IFN-γ (B), IL-4 (C), and IL-17 (D) by ELISA. The proliferation and cytokine levels of cells stimulated with buffer as a negative control were subtracted. Results are presented as stacked bar graphs. (E-F) The total amounts of cytokines secreted after stimulation with FVIII2194-2213 at the 3 concentrations indicated in panel A were summed, and ratios of these total levels were calculated. In all panels, clones are grouped according to their cytokine secretion profiles.

Proliferation and cytokine secretion of T-cell clones isolated from subject 17A 19 weeks and 21 months after inhibitor development and from subject 32A at one time point. Resting T-cell clones were stimulated with FVIII2194-2213 (0.1, 1.0, and 10 μM) presented on irradiated PBMCs from an unrelated DRB1*0101 donor. Proliferation (n = 3) was measured by addition of [3H]thymidine at 48 hours, and cells were harvested 18 hours later (A). Cell supernatants were collected after 48 hours to measure IFN-γ (B), IL-4 (C), and IL-17 (D) by ELISA. The proliferation and cytokine levels of cells stimulated with buffer as a negative control were subtracted. Results are presented as stacked bar graphs. (E-F) The total amounts of cytokines secreted after stimulation with FVIII2194-2213 at the 3 concentrations indicated in panel A were summed, and ratios of these total levels were calculated. In all panels, clones are grouped according to their cytokine secretion profiles.

Close Modal

or Create an Account

Close Modal
Close Modal